These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence. Ragnoli B; Da Re B; Galantino A; Kette S; Salotti A; Malerba M Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240292 [TBL] [Abstract][Full Text] [Related]
7. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy. Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M Expert Rev Respir Med; 2021 Aug; 15(8):1003-1011. PubMed ID: 33667146 [TBL] [Abstract][Full Text] [Related]
11. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood. Kumar R; Rivkin MJ; Raffini L J Thromb Haemost; 2023 Sep; 21(9):2313-2326. PubMed ID: 37268064 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 associated coagulopathy and thrombosis in cancer. Levi M; van Es N Thromb Res; 2022 May; 213 Suppl 1():S72-S76. PubMed ID: 36210564 [TBL] [Abstract][Full Text] [Related]
13. COVID-19-related thrombotic complications experience before and during delta wave. Manzur-Pineda K; O'Neil CF; Bornak A; Lalama MJ; Shao T; Kang N; Kennel-Pierre S; Tabbara M; Velazquez OC; Rey J J Vasc Surg; 2022 Nov; 76(5):1374-1382.e1. PubMed ID: 35700857 [TBL] [Abstract][Full Text] [Related]
14. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F; Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170 [TBL] [Abstract][Full Text] [Related]
15. Thromboprophylaxis Outcome in Childhood SARS-CoV-2 Infection: A Single-Center Experience. Karimi M; Sanaei Dashti A; Haghpanah S; Mansoori Y; Zarei T; Amanati A; Bordbar M J Pediatr Hematol Oncol; 2023 Jan; 45(1):e97-e102. PubMed ID: 36162044 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications. Violi F; Pignatelli P; Cammisotto V; Carnevale R; Nocella C Kardiol Pol; 2021; 79(11):1197-1205. PubMed ID: 34847237 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 induced coagulopathy and potential role of anticoagulation: Scoping review of literature. Zehra Naseem ; Khakwani MM; Maaha Ayub ; Ahmed Ayaz ; Bushra Jamil ; Arshad A Monaldi Arch Chest Dis; 2022 Jan; 92(4):. PubMed ID: 35086326 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 Coagulopathy: From Pathogenesis to Treatment. Alnima T; Mulder MMG; van Bussel BCT; Ten Cate H Acta Haematol; 2022; 145(3):282-296. PubMed ID: 35499460 [TBL] [Abstract][Full Text] [Related]
20. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]